How does the EMA support innovation in cancer treatment?
The EMA has several initiatives to foster innovation in cancer treatment: 1. PRIME Scheme: Provides early and enhanced support to medicines that address unmet medical needs. 2. Adaptive Pathways: Allows for a more flexible approach to the development and authorization of innovative medicines. 3. Scientific Advice: Offers guidance to developers on the best methods and study designs to generate robust data.
